Summary

The global Opioid Induced Constipation Drugs market will reach Volume Million USD in 2019 and with a CAGR xx% between 2020-2026.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):

Lubiprostone 
Methyl Naltrexone Bromide 
Naldemedine 
Alvimopan 
Others
Demand Coverage (Market Size & Forecast, Consumer Distribution):
Hospital Pharmacies 
Retail Pharmacies 
Online Pharmacies

Company Coverage (Sales data, Main Products & Services etc.):

Ironwood Pharmaceuticals Inc 
Daiichi Sankyo Co Ltd 
Pfizer 
Progenics Pharmaceuticals Inc 
Shionogi & Co., Ltd 
Allergan Plc 
Nektar Therapeutics 
Purdue Pharma 
S.L.A. Pharma AG 
Mundipharma International Limited 
Ono Pharmaceutical Co., Ltd 
Takeda Pharmaceutical Company Limited 
Theravance Biopharma Inc 
Valeant Pharmaceuticals International 
Cosmo Pharmaceuticals SA 
Daewoong Pharmaceutical 
C.B. Fleet Company 
Sucampo Pharmaceuticals

Major Region

Market
North America
Europe
Asia-Pacific
South America
Middle East & Africa